1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
| 10011085-1ea | SIRT1 FRET Developer |
1 ea
|
 |
||||||||||
| 10011086-1ea | SIRT1 FRET Fluorophore |
1 ea
|
|
||||||||||
| 10011083-1ea | SIRT1 FRET NAD+ |
1 ea
|
|
||||||||||
| 10011082-1ea | SIRT1 FRET Peptide |
1 ea
|
|
||||||||||
| 10011084-1ea | SIRT1 FRET Stop Solution |
1 ea
|
|
||||||||||
| 10010991-96Well | SIRT1 FRET-Based Screening Assay Kit |
96 Well
|
|
||||||||||
| 14407-1mg | SIRT1/2 Inhibitor IV |
1 mg
|
|
||||||||||
| 14407-10mg | SIRT1/2 Inhibitor IV |
10 mg
|
|
||||||||||
| 14407-25mg | SIRT1/2 Inhibitor IV |
25 mg
|
|
||||||||||
| 14407-5mg | SIRT1/2 Inhibitor IV |
5 mg
|
|
||||||||||
| 10011191-100µg | SIRT2 (human recombinant) |
100 µg
|
|
||||||||||
| 700282-1ea | SIRT2 (human recombinant) Direct Assay Reagent |
1 ea
|
|
||||||||||
| 700281-1ea | SIRT2 Direct Assay Buffer (10X) |
1 ea
|
|
||||||||||
| 700286-1ea | SIRT2 Direct Developer |
1 ea
|
|
||||||||||
| 700280-96Well | SIRT2 Direct Fluorescent Screening Assay Kit |
96 Well
|
|
||||||||||
| 700287-1ea | SIRT2 Direct Fluorophore |
1 ea
|
|
||||||||||
| 700284-1ea | SIRT2 Direct NAD+ |
1 ea
|
|
||||||||||
| 700285-1ea | SIRT2 Direct Nicotinamide |
1 ea
|
|
||||||||||
| 700283-1ea | SIRT2 Direct Peptide |
1 ea
|
|
||||||||||
| 10011194-100µg | SIRT3 (human recombinant) |
100 µg
|
|
||||||||||
| 10012541-1ea | SIRT3 (human recombinant) Direct Assay Reagent |
1 ea
|
|
||||||||||
| 10012540-1ea | SIRT3 Direct Assay Buffer (10X) |
1 ea
|
|
||||||||||
| 10012545-1ea | SIRT3 Direct Developer |
1 ea
|
|
||||||||||
| 10011566-96Well | SIRT3 Direct Fluorescent Screening Assay Kit |
96 Well
|
|
||||||||||
| 10012546-1ea | SIRT3 Direct Fluorophore |
1 ea
|
|
||||||||||
| 10012543-1ea | SIRT3 Direct NAD+ |
1 ea
|
|
||||||||||
| 10012544-1ea | SIRT3 Direct Nicotinamide |
1 ea
|
|
||||||||||
| 10012542-1ea | SIRT3 Direct Peptide |
1 ea
|
|
||||||||||
| 10317-100µg | SIRT4 (human recombinant) |
100 µg
|
|
||||||||||
| 10318-100µg | SIRT5 (human recombinant) |
100 µg
|
|
||||||||||
| 10315-100µg | SIRT6 (human recombinant) |
100 µg
|
|
||||||||||
| 10316-100µg | SIRT7 (human recombinant) |
100 µg
|
|
||||||||||
| 13477-1ea | SIRT7 Polyclonal Antibody |
1 ea
|
|
||||||||||
| 10523-10mg | Sirtinol |
10 mg
|
|
||||||||||
| 10523-25mg | Sirtinol |
25 mg
|
|
||||||||||
| 10523-5mg | Sirtinol |
5 mg
|
|
||||||||||
| 10523-50mg | Sirtinol |
50 mg
|
|
||||||||||
| 21046-1g | Sisomicin |
1 g
|
|
||||||||||
| 21046-100mg | Sisomicin |
100 mg
|
|
||||||||||
| 21046-50mg | Sisomicin |
50 mg
|
|
||||||||||
| 21046-500mg | Sisomicin |
500 mg
|
|
||||||||||
| 81290-1g | S-isopropyl Isothiourea (hydrobromide) |
1 g
|
|
||||||||||
| 81290-100mg | S-isopropyl Isothiourea (hydrobromide) |
100 mg
|
|
||||||||||
| 81290-50mg | S-isopropyl Isothiourea (hydrobromide) |
50 mg
|
|
||||||||||
| 81290-500mg | S-isopropyl Isothiourea (hydrobromide) |
500 mg
|
|
||||||||||
| 13252-1g | Sitagliptin (phosphate) |
1 g
|
|
||||||||||
| 13252-100mg | Sitagliptin (phosphate) |
100 mg
|
|
||||||||||
| 13252-250mg | Sitagliptin (phosphate) |
250 mg
|
|
||||||||||
| 13252-50mg | Sitagliptin (phosphate) |
50 mg
|
|
||||||||||
| 700214-500nmol | Sitagliptin Positive Control Inhibitor |
500 nmol
|
|
||||||||||
| 17779-10mg | Sivelestat (sodium salt hydrate) |
10 mg
|
|
||||||||||
| 17779-25mg | Sivelestat (sodium salt hydrate) |
25 mg
|
|
||||||||||
| 17779-5mg | Sivelestat (sodium salt hydrate) |
5 mg
|
|
||||||||||
| 17779-50mg | Sivelestat (sodium salt hydrate) |
50 mg
|
|
||||||||||
| 19999-1mg | SJ 172550 |
1 mg
|
|
||||||||||
| 19999-10mg | SJ 172550 |
10 mg
|
|
||||||||||
| 19999-5mg | SJ 172550 |
5 mg
|
|
||||||||||
| 16974-1mg | Skepinone-L |
1 mg
|
|
||||||||||
| 16974-10mg | Skepinone-L |
10 mg
|
|
||||||||||
| 16974-5mg | Skepinone-L |
5 mg
|
|
||||||||||
| 16974-500µg | Skepinone-L |
500 µg
|
|
||||||||||
| 19150-10mg | SKF 38393 (hydrobromide) |
10 mg
|
|
||||||||||
| 19150-100mg | SKF 38393 (hydrobromide) |
100 mg
|
|
||||||||||
| 19150-25mg | SKF 38393 (hydrobromide) |
25 mg
|
|
||||||||||
| 19150-50mg | SKF 38393 (hydrobromide) |
50 mg
|
|
||||||||||
| 15040-1g | SKF 525A (hydrochloride) |
1 g
|
|
||||||||||
| 15040-100mg | SKF 525A (hydrochloride) |
100 mg
|
|
||||||||||
| 15040-250mg | SKF 525A (hydrochloride) |
250 mg
|
|
||||||||||
| 15040-500mg | SKF 525A (hydrochloride) |
500 mg
|
|
||||||||||
| 22220-1mg | SKF 83959 (hydrobromide) |
1 mg
|
|
||||||||||
| 22220-10mg | SKF 83959 (hydrobromide) |
10 mg
|
|
||||||||||
| 22220-25mg | SKF 83959 (hydrobromide) |
25 mg
|
|
||||||||||
| 22220-5mg | SKF 83959 (hydrobromide) |
5 mg
|
|
||||||||||
| 11953-1mg | SKF 86466 (hydrochloride) |
1 mg
|
|
||||||||||
| 11953-10mg | SKF 86466 (hydrochloride) |
10 mg
|
|
||||||||||
| 11953-25mg | SKF 86466 (hydrochloride) |
25 mg
|
|
||||||||||
| 11953-5mg | SKF 86466 (hydrochloride) |
5 mg
|
|
||||||||||
| 10009312-1mg | SKF 96365 (hydrochloride) |
1 mg
|
|
||||||||||
| 10009312-10mg | SKF 96365 (hydrochloride) |
10 mg
|
|
||||||||||
| 10009312-5mg | SKF 96365 (hydrochloride) |
5 mg
|
|
||||||||||
| 10009312-50mg | SKF 96365 (hydrochloride) |
50 mg
|
|
||||||||||
| 21561-1mg | SKLB 610 |
1 mg
|
|
||||||||||
| 21561-10mg | SKLB 610 |
10 mg
|
|
||||||||||
| 21561-25mg | SKLB 610 |
25 mg
|
|
||||||||||
| 21561-5mg | SKLB 610 |
5 mg
|
|
||||||||||
| 19891-10mg | SKQ1 (bromide) |
10 mg
|
|
||||||||||
| 19891-25mg | SKQ1 (bromide) |
25 mg
|
|
||||||||||
| 19891-5mg | SKQ1 (bromide) |
5 mg
|
|
||||||||||
| 19891-50mg | SKQ1 (bromide) |
50 mg
|
|
||||||||||
| 13102-1mg | Skyrin |
1 mg
|
|
||||||||||
| 15225-1g | SL 01 |
1 g
|
|
||||||||||
| 15225-250mg | SL 01 |
250 mg
|
|
||||||||||
| 15225-500mg | SL 01 |
500 mg
|
|
||||||||||
| 11704-1mg | SL 0101-1 |
1 mg
|
|
||||||||||
| 11704-10mg | SL 0101-1 |
10 mg
|
|
||||||||||
| 11704-5mg | SL 0101-1 |
5 mg
|
|
||||||||||
| 11704-500µg | SL 0101-1 |
500 µg
|
|
||||||||||
| 15598-1mg | SL 327 |
1 mg
|
|
||||||||||
| 15598-10mg | SL 327 |
10 mg
|
|
||||||||||
| 15598-25mg | SL 327 |
25 mg
|
|
||||||||||